Nucleo-cytoplasmic transport defects and protein aggregates in neurodegeneration

Transl Neurodegener. 2020 Jul 3;9(1):25. doi: 10.1186/s40035-020-00205-2.

Abstract

In the ongoing process of uncovering molecular abnormalities in neurodegenerative diseases characterized by toxic protein aggregates, nucleo-cytoplasmic transport defects have an emerging role. Several pieces of evidence suggest a link between neuronal protein inclusions and nuclear pore complex (NPC) damage. These processes lead to oxidative stress, inefficient transcription, and aberrant DNA/RNA maintenance. The clinical and neuropathological spectrum of NPC defects is broad, ranging from physiological aging to a suite of neurodegenerative diseases. A better understanding of the shared pathways among these conditions may represent a significant step toward dissecting their underlying molecular mechanisms, opening the way to a real possibility of identifying common therapeutic targets.

Keywords: Aging; Neurodegeneration; Neurodegenerative disease; Nuclear pore complex; Nucleo–cytoplasmic transport; Protein aggregate.

Publication types

  • Review

MeSH terms

  • Active Transport, Cell Nucleus / physiology*
  • Animals
  • Cell Nucleus / genetics
  • Cell Nucleus / metabolism*
  • Cell Nucleus / pathology
  • Humans
  • Inclusion Bodies / genetics
  • Inclusion Bodies / metabolism
  • Inclusion Bodies / pathology
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / pathology
  • Nuclear Pore / genetics
  • Nuclear Pore / metabolism
  • Nuclear Pore / pathology
  • Protein Aggregates / physiology*
  • Superoxide Dismutase-1 / genetics
  • Superoxide Dismutase-1 / metabolism

Substances

  • Protein Aggregates
  • SOD1 protein, human
  • Superoxide Dismutase-1